Natalie Weltz is an accomplished professional in the field of quality control and analytical quality, boasting extensive experience in leadership roles. Currently serving as the Director of Quality Control at Apogee Therapeutics, Natalie has held significant positions including Head of Quality at Solvias and Head of External Analytical Quality at both Pfizer and Seagen. Prior to these roles, Natalie contributed to Biogen as the Head of Quality Strategy and Business Process, as well as taking on various managerial positions focused on QC Analytical Technology for clinical testing and support.
This person is not in any teams
This person is not in any offices
Apogee Therapeutics
1 followers
Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.